- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07468565
Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) (SMILES)
A Bicenter Retrospective Comparative Study of the Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique
Hirschsprung disease (HD) is a rare congenital disorder of the enteric nervous system, affecting approximately 1 in 5,000 live births. It is characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction due to impaired peristalsis. Surgical treatment consists of resection of the aganglionic segment-most commonly rectosigmoid-followed by a colo-rectal, colo-anal, or ileo-anal anastomosis.
Among colo-anal pull-through procedures, the Swenson technique was historically performed through an exclusively transanal approach, which carries a risk of sphincter injury correlated with operative duration. More recently, combined laparoscopic and transanal approaches have been developed to reduce this risk, although they may be associated with higher overall complication and reoperation rates.
The Swenson procedure can be performed using a single-port laparoscopic approach, a technique that is sparsely described in the literature and rarely practiced in France. Single-port laparoscopy represents an emerging surgical technique that, despite increased technical complexity for surgeons, may further enhance postoperative recovery and cosmetic outcomes compared to conventional multiport laparoscopy.
The objective of this study is to describe the outcomes of single-port laparoscopic Swenson pull-through in children with Hirschsprung disease and to compare them with outcomes obtained using more conventional approaches, namely exclusive transanal surgery or combined multiport laparoscopic and transanal approaches.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: SCHMITT Françoise
- Phone Number: +33 0241353637
- Email: FrSchmitt@chu-angers.fr
Study Contact Backup
- Name: SCHMITT Françoise
- Email: FrSchmitt@chu-angers.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children under 16 years of age
- Diagnosis of Hirschsprung disease confirmed by initial rectal biopsy and postoperative pathological examination
- Primary Swenson coloanal pull-through performed at Angers or Caen University Hospital between January 1, 2010 and June 30, 2025
Exclusion criteria
- Parental or legal guardian opposition to the use of medical data for research purposes
- Hirschsprung disease treated with other surgical techniques (Duhamel, Soave, De La Torre, TERPT)
- Patients operated on in another hospital
- Patients who underwent rectosigmoid resection for causes of constipation other than Hirschsprung disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SIL-Swenson
Swenson coloanal pullthrough with single incision laparoscopy
|
TA-Swenson consist of total trananal endorectal pullthrough after a short submucosal dissection of the last part of the rectum. Laparoscopy-assisted Swenson pull-through consists of laparoscopic mobilization of the aganglionic colon with intraoperative level confirmation, followed by a transanal resection of the aganglionic segment and a primary coloanal anastomosis |
|
CL-Swenson
Swenson coloanal pullthrough with conventional (multiport) laparoscopy
|
TA-Swenson consist of total trananal endorectal pullthrough after a short submucosal dissection of the last part of the rectum. Laparoscopy-assisted Swenson pull-through consists of laparoscopic mobilization of the aganglionic colon with intraoperative level confirmation, followed by a transanal resection of the aganglionic segment and a primary coloanal anastomosis |
|
TA-Swenson
Swenson coloanal pullthrough with exclusive trananal approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare the short-term effectiveness of different surgical laparoscopic approaches used for the Swenson technique.
Time Frame: From surgery to 12 months postoperatively
|
Short-term effectiveness, defined as spontaneous bowel transit without obstructive-spectrum events during the first postoperative year, including:
|
From surgery to 12 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare intraoperativensurgical efficiency according to surgical approach
Time Frame: During surgery (day 0)
|
Surgical efficiency, defined as operative time for coloanal anastomosis completion without conversion, including the approach for intraoperative frozen-section biopsy.
|
During surgery (day 0)
|
|
To compare immediate postoperative recovery
Time Frame: At hospital discharge (average 5 days)
|
Recovery, defined as hospital discharge in good health, which includes:
|
At hospital discharge (average 5 days)
|
|
Short-term complications
Time Frame: From hospital discharge to 30 days after surgery
|
All early postoperative complications graded according to the Clavien-Madadi classification
|
From hospital discharge to 30 days after surgery
|
|
Long-term complications
Time Frame: From 31 days after surgery up to the last clinical follow-up visit (mean follow-up: 5.5 years)
|
All late postoperative complications graded according to the Clavien-Madadi classification
|
From 31 days after surgery up to the last clinical follow-up visit (mean follow-up: 5.5 years)
|
|
Long-term continence outcomes
Time Frame: Assessed after toilet training age (≥3-4 years old) and up to the last clinical follow-up visit (mean follow-up: 5.5 years)
|
Assessed using the Krickenbeck score, which includes:
|
Assessed after toilet training age (≥3-4 years old) and up to the last clinical follow-up visit (mean follow-up: 5.5 years)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: SCHMITT Françoise, University hospital of Angers
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 49RC25_0501
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hirschsprung Disease
-
St. Justine's HospitalRecruitingHirschsprung Disease | Ganglion | Hirschsprung Disease, Long-Segment | HypoganglionosisCanada
-
McMaster UniversityMcMaster Pediatric Surgery Rresearch Collaborative (MPSRC)Not yet recruitingInflammatory Bowel Diseases | Necrotizing Enterocolitis | Meconium Ileus | Bowel Obstruction | Colostomy | Elective Surgery | Hirschsprung Disease - Pull Through
-
Weibing TangRecruitingConstipation | Incontinence | Long Term Adverse Effects | Hirschsprung Disease, Long-SegmentChina
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingHirschsprung's DiseaseFrance
-
Al-Azhar UniversityCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingHirschsprung Disease
-
Egyptian Biomedical Research NetworkCompletedTransanal Versus Laparoscopic-assisted Transanal Through in the Management of Hirschsprung's DiseasePediatric Disorder | Hirschprung's DiseaseEgypt
-
NYU Langone HealthNew York UniversityRecruiting
-
University of Southern DenmarkCompletedHirschsprung DiseaseDenmark
-
Erasmus Medical CenterUnknown
Clinical Trials on transanal or laparoscopy assisted Swenson coloanal pullthrough
-
National Cancer Center, KoreaActive, not recruitingRectal CancerKorea, Republic of